These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11596979)

  • 1. The search for the genetic lesion in Ashkenazi Jews with Classic Tay-Sachs disease.
    Myerowitz R
    Adv Genet; 2001; 44():137-43. PubMed ID: 11596979
    [No Abstract]   [Full Text] [Related]  

  • 2. Splice junction mutation in some Ashkenazi Jews with Tay-Sachs disease: evidence against a single defect within this ethnic group.
    Myerowitz R
    Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3955-9. PubMed ID: 3375249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origin and spread of the 1278insTATC mutation causing Tay-Sachs disease in Ashkenazi Jews: genetic drift as a robust and parsimonious hypothesis.
    Frisch A; Colombo R; Michaelovsky E; Karpati M; Goldman B; Peleg L
    Hum Genet; 2004 Mar; 114(4):366-76. PubMed ID: 14727180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation in the HEXA gene specific to Tay-Sachs disease carriers of Jewish Iraqi origin.
    Karpati M; Peleg L; Gazit E; Akstein E; Goldman B
    Clin Genet; 2000 May; 57(5):398-400. PubMed ID: 10852376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
    Kronn D; Jansen V; Ostrer H
    Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymerase chain reaction-generated heteroduplexes from Ashkenazi Tay-Sachs carriers with an insertion mutation can be detected on agarose gels.
    Shore S; Myerowitz R
    Am J Hum Genet; 1990 Jul; 47(1):169. PubMed ID: 2349947
    [No Abstract]   [Full Text] [Related]  

  • 7. Tay-Sachs disease and HEXA mutations among Moroccan Jews.
    Kaufman M; Grinshpun-Cohen J; Karpati M; Peleg L; Goldman B; Akstein E; Adam A; Navon R
    Hum Mutat; 1997; 10(4):295-300. PubMed ID: 9338583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Tay-Sachs disease screening program in the U.S. as a model for the control of genetic disease: an historical view.
    Edelson PJ
    Health Matrix Clevel; 1997; 7(1):125-33. PubMed ID: 10167171
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests.
    Triggs-Raine BL; Feigenbaum AS; Natowicz M; Skomorowski MA; Schuster SM; Clarke JT; Mahuran DJ; Kolodny EH; Gravel RA
    N Engl J Med; 1990 Jul; 323(1):6-12. PubMed ID: 2355960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unusual genotype in an Ashkenazi Jewish patient with Tay-Sachs disease.
    Shore S; Tomczak J; Grebner EE; Myerowitz R
    Hum Mutat; 1992; 1(6):486-90. PubMed ID: 1301958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.
    Rozenberg R; Pereira Lda V
    Sao Paulo Med J; 2001 Jul; 119(4):146-9. PubMed ID: 11500789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygosity for the common Ashkenazi jewish Tay-Sachs +1 IVS-12 splice-junction mutation: first report.
    Strasberg P; Warren I; Skomorowski MA; Feigenbaum A
    Hum Mutat; 1997; 10(1):82-3. PubMed ID: 9222766
    [No Abstract]   [Full Text] [Related]  

  • 13. A gel electrophoretic assay for detecting the insertion defect in Ashkenazi Jewish carriers of Tay-Sachs disease.
    Shore S; Myerowitz R
    Anal Biochem; 1990 Apr; 186(1):179-81. PubMed ID: 2356966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical Issues with Genetic Testing for Tay-Sachs.
    Clayton T
    J Christ Nurs; 2017; 34(4):246-249. PubMed ID: 28902054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid nonradioactive tracer method for detecting carriers of the major Ashkenazi Jewish Tay-Sachs disease mutations.
    Strasberg PM; Clarke JT
    Clin Chem; 1992 Nov; 38(11):2249-55. PubMed ID: 1424119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease.
    Navon R; Proia RL
    Science; 1989 Mar; 243(4897):1471-4. PubMed ID: 2522679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of the Tay-Sachs disease splice and insertion mutations in the UK Ashkenazi Jewish population.
    Landels EC; Ellis IH; Fensom AH; Green PM; Bobrow M
    J Med Genet; 1991 Mar; 28(3):177-80. PubMed ID: 1828838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-specific screening by mutation analysis for diseases frequent in Ashkenazi Jews.
    DeMarchi JM; Caskey CT; Richards CS
    Hum Mutat; 1996; 8(2):116-25. PubMed ID: 8844209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and prevention in Tay-Sachs disease: origins, update, and impact.
    Kaback MM
    Adv Genet; 2001; 44():253-65. PubMed ID: 11596988
    [No Abstract]   [Full Text] [Related]  

  • 20. PCR analysis of hair root specimens to detect Tay-Sachs disease carriers in Ashkenazi Jews.
    Brillante R; Yang V; Proos A; Burnett L
    Clin Chem; 1995 Feb; 41(2):321-2. PubMed ID: 7874790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.